SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001178913-17-003489
Filing Date
2017-12-28
Accepted
2017-12-28 16:33:11
Documents
13

Document Format Files

Seq Description Document Type Size
1 F-3 zk1720935.htm F-3 617889
2 ARTICLES OF ASSOCIATION OF THE REGISTRANT, AS AMENDED exhibit_2-1.htm EX-2.1 183650
3 OPINION OF YIGAL ARNON & CO. exhibit_5-1.htm EX-5.1 58926
4 OPINION OF MORRISON & FOERSTER LLP exhibit_5-2.htm EX-5.2 20444
5 COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES exhibit_12-1.htm EX-12.1 53166
6 CONSENT OF KESSELMAN AND KESSELMAN exhibit_23-1.htm EX-23.1 4876
7 STATEMENT OF ELIGIBILITY OF THE BANK OF NEW YORK MELLON, AS TRUSTEE exhibit_25-1.htm EX-25.1 78567
8 image0.jpg GRAPHIC 77707
9 image1.jpg GRAPHIC 1779
10 image00003.jpg GRAPHIC 955
11 image00004.jpg GRAPHIC 6585
12 image00005.jpg GRAPHIC 21109
13 image00008.jpg GRAPHIC 21314
  Complete submission text file 0001178913-17-003489.txt   1197470
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-222332 | Film No.: 171278737
SIC: 2834 Pharmaceutical Preparations